SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-19-003575
Filing Date
2019-11-14
Accepted
2019-11-13 17:34:13
Documents
3
Period of Report
2019-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm 8-K 22137
2 PRESS RELEASE cns_ex9901.htm EX-99.1 6821
3 GRAPHIC image_001.jpg GRAPHIC 4090
  Complete submission text file 0001683168-19-003575.txt   36007
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 191215496
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences